2020
DOI: 10.1016/j.molcel.2020.11.034
|View full text |Cite
|
Sign up to set email alerts
|

HEPN-MNT Toxin-Antitoxin System: The HEPN Ribonuclease Is Neutralized by OligoAMPylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(26 citation statements)
references
References 61 publications
0
20
2
Order By: Relevance
“…One identified TA pair was predicted as an MNT/HEPN-like system, which is common to thermophiles ( 38 ). MNT (minimal nucleotidyltransferase)-type antitoxins inactivate their cognate HEPN (higher eukaryotes and prokaryotes nucleotide-binding) ribonucleases by AMPylation ( 39 ). The remaining TAs were identified as the VapBC type, including Saci_2184 (referred to here as VapB14).…”
Section: Resultsmentioning
confidence: 99%
“…One identified TA pair was predicted as an MNT/HEPN-like system, which is common to thermophiles ( 38 ). MNT (minimal nucleotidyltransferase)-type antitoxins inactivate their cognate HEPN (higher eukaryotes and prokaryotes nucleotide-binding) ribonucleases by AMPylation ( 39 ). The remaining TAs were identified as the VapBC type, including Saci_2184 (referred to here as VapB14).…”
Section: Resultsmentioning
confidence: 99%
“…A second example of inactivation via post‐translational modification is the poly‐adenylation found in the mntA‐hepT family 47,48 . In this case, binding of antitoxin MntA is insufficient to fully inhibit HepT toxicity and the antitoxin MntA additionally functions as an adenylyltransferase.…”
Section: Regulation Of Toxin Activity By the Antitoxinmentioning
confidence: 99%
“…The type II, IV, V, VI, and VII TA system toxins and antitoxins are proteins. Antitoxin proteins block the toxicity of the toxins via the following mechanisms: direct protein–protein interactions (type II) [ 4 , 5 , 6 ], compete with and remove the toxin from its target (type IV) [ 7 , 8 ], cleave the toxin mRNA (type V) [ 9 ], promote toxin degradation (type VI) [ 10 ], or regulate post-translational chemical modifications (type VII) [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%